Omeprazole and dementia: recent studies deny a direct link to Alzheimer’s in the elderly
Specialists in neurology and gastroenterology say that omeprazole, a medication widely prescribed to treat gastroesophageal reflux and ulcers, does not cause dementia or Alzheimer’s, according to updated scientific analyses. The suspicion arose in 2014 with a German observational study involving more than 70,000 elderly people, which identified an association between proton pump inhibitors and a higher incidence of cognitive decline. However, subsequent research, such as a 2024 meta-analysis with data from more than 500,000 patients, has not confirmed this causal relationship.
The current focus is on the appropriate use of the medicine, as continuous unsupervised consumption can interfere with the absorption of essential nutrients, although without a direct impact on the brain.
- Vitamin B12 deficiency occurs in up to 20% of chronic users after two years.
- Low magnesium levels affect 10% to 15% of long-term cases.
- Nutritional replacement reverses symptoms in 80% of affected patients.
Source of initial suspicion
A study published in JAMA Neurology in 2014 looked at prescriptions in elderly Germans and found 44% more cases of dementia among regular users of PPIs.
Researchers highlighted limitations, such as samples restricted to patients with multiple comorbidities, including diabetes and cardiovascular history.
Confounding factors, such as polypharmacy, distorted the initial results.
Limitations of observational studies
Observational research measures associations, but does not establish causality, according to a review in Neurology in 2017 with 250 thousand participants.
Finnish work concluded that variables such as advanced age and irregular diet better explain cognitive decline.
Meta-analyses from 2022 and 2024, involving global data, reinforced the absence of a direct link between PPIs and Alzheimer’s.
Indirect mechanism via nutrients
Prolonged suppression of gastric acid reduces the release of vitamin B12 from foods, leading to deficiencies in 15% to 25% of users after 18 months, according to the Journal of the American Geriatrics Society.
This deficiency affects neuronal metabolism, causing fatigue and memory lapses that are reversible with supplementation.
However, the medicine itself does not act toxically on the central nervous system, unlike environmental toxins.
Iron and magnesium also face compromised absorption, increasing the risk of anemia and muscle weakness in the elderly.
Evolution of proton inhibitors
Since the launch of omeprazole in 1989, options such as pantoprazole and esomeprazole have emerged with more stable profiles and less nutritional interference.
Studies from 2023 indicate that minimum doses, below 20 mg daily, minimize side effects in 70% of casess.
The class has evolved into personalized treatments, based on genetic tests for liver metabolism.
Groups most vulnerable
Elderly people over 65 years old represent 60% of chronic prescriptions, with a greater propensity for drug interactions.
Patients with polypharmacy face a 30% greater chance of associated nutritional deficiencies.
Monitoring includes annual B12 tests and bone densitometry to prevent fractures.
Leia Também
O que acontece no cérebro ao passar a noite em claro? Estudo inédito em humanos revela alterações sinápticas
Diagnóstico precoce e prevenção são cruciais em São Paulo após salto de 97% nos atendimentos por diabetes
Estudo detalha eficácia e duração ideal da terapia do riso para combater depressão e ansiedade
Postmenopausal women require extra attention due to the risk combined with low calcium intake.
Responsible use strategies
Doctors recommend therapeutic breaks every three months for clinical reassessment.
Alternatives include fast-acting antacids for sporadic symptoms, reducing dependence in 40% of cases.
Education on an alkaline diet, rich in leafy vegetables, complements treatment without increasing costs.
Regular monitoring ensures effectiveness without compromising the absorption of essential minerals.
Changes in intestinal microbiota
Acid blockage favors the growth of bacteria such as Clostridium difficile, increasing infections by 2 to 3 times among long-term users.
MuFlora dances affect global digestion, but do not directly influence cognition.
Adjuvant probiotics restore balance in 75% of patients after six weeks.
Prescription recommendations
Gastroenterologists emphasize precise indication, limiting use to the initial eight weeks for ulcers.
Quarterly reassessments adjust doses according to residual symptoms.
Integration with nutritionists prevents deficiencies in at-risk populations.
The focus remains on the lowest effective dose to maximize gastrointestinal benefits.
Essential nutrition tracking
B12 tests should occur after 12 months of continuous use, detecting early changes.
Oral supplementation corrects levels in 90% of cases without interrupting the main treatment.
Annual densitometry tracks bone impacts in chronic users.
This integrated approach preserves cognitive function over time.
